Benzinga | Jan 27, 2021 04:04PM EST

Cantor Fitzgerald Initiates Coverage On EyePoint Pharmaceuticals with Overweight Rating, Announces Price Target of $22

Cantor Fitzgerald initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight rating and announces Price Target of $22.